{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:21:04Z","timestamp":1770268864408,"version":"3.49.0"},"reference-count":30,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"unspecified","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","award":["RS170309"],"award-info":[{"award-number":["RS170309"]}],"id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,1,5]]},"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the association between low-dose aspirin and the incidence of colorectal cancer (CRC), gastric cancer (GC), oesophageal cancer (EC) and gastrointestinal bleeding (GIB) in adults without established atherosclerotic cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cohort study with propensity score matching of new-users of aspirin to non-users.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Clinical Data Analysis and Reporting System database, Hong Kong.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Adults \u226540 years with a prescription start date of either low-dose aspirin (75\u2013300\u2009mg\/daily) or paracetamol (non-aspirin users) between 1 January 2004 to 31 December 2008 without a history of atherosclerotic cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>The primary outcome was the first diagnosis of gastrointestinal cancer (either CRC, GC or EC) and the secondary outcome was GIB. Individuals were followed from index date of prescription until the earliest occurrence of an outcome of interest, an incident diagnosis of any type of cancer besides the outcome, death or until 31 December 2017. A competing risk survival analysis was used to estimate HRs and 95% CIs with death as the competing risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After matching, 49 679 aspirin and non-aspirin users were included. The median (IQR) follow-up was 10.0 (6.4) years. HRs for low-dose aspirin compared with non-aspirin users were 0.83 for CRC (95%\u2009CI, 0.76 to 0.91), 0.77 for GC (95%\u2009CI, 0.65 to 0.92) and 0.88 for EC (95% CI, 0.67 to 1.16). Patients prescribed low-dose aspirin had an increased risk of GIB (HR 1.15, 95%\u2009CI, 1.11 to 1.20), except for patients prescribed proton pump inhibitors or histamine H2-receptor antagonists (HR 1.03, 95%\u2009CI, 0.96 to 1.10).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this cohort study of Chinese adults, patients prescribed low-dose aspirin had reduced risks of CRC and GC and an increased risk of GIB. Among the subgroup of patients prescribed gastroprotective agents at baseline, however, the association with GIB was attenuated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-050510","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T11:01:46Z","timestamp":1643972506000},"page":"e050510","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1084-1829","authenticated-orcid":false,"given":"Jessica J P","family":"Shami","sequence":"first","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China"},{"name":"Digital and Data Innovation, AstraZeneca Global R&D (China) Co., Ltd, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swathi","family":"Pathadka","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6275-1147","authenticated-orcid":false,"given":"Eric Yuk Fai","family":"Wan","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China"},{"name":"Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China"},{"name":"Department of Family Medicine and Primary Care, University of Hong Kong, Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7895-198X","authenticated-orcid":false,"given":"Joseph Edgar","family":"Blais","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pareen","family":"Vora","sequence":"additional","affiliation":[{"name":"Epidemiology, Bayer AG, Leverkusen, Nordrhein-Westfalen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montse","family":"Soriano-Gabarr\u00f3","sequence":"additional","affiliation":[{"name":"Epidemiology, Bayer Pharma AG, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka Shing","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Hong Kong, Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W K","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Hong Kong, Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian C K","family":"Wong","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China"},{"name":"Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China"},{"name":"Centre for Medicines Optimisation Research and Education, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther W","family":"Chan","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China"},{"name":"Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China"},{"name":"Department of Pharmacy, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China"},{"name":"Shenzhen Institute of Research and Innovation, The University of Hong Kong, Shenzhen, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"2025121409283030000_12.2.e050510.1","unstructured":"World Cancer Research Fund . Colorectal cancer statistics. Available: https:\/\/www.wcrf.org\/dietandcancer\/cancer-trends\/colorectal-cancer-statistics [Accessed 4 Oct 2020]."},{"key":"2025121409283030000_12.2.e050510.2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310912"},{"key":"2025121409283030000_12.2.e050510.3","unstructured":"International Agency for Research on Cancer WHO. Cancer today 2018. Available: https:\/\/gco.iarc.fr\/today\/ [Accessed 12 Dec 2020]."},{"key":"2025121409283030000_12.2.e050510.4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijcard.2017.06.052","article-title":"Incidence of colorectal cancer in new users and non-users of low-dose aspirin without existing cardiovascular disease: a cohort study using the health improvement network","volume":"248","author":"Cea Soriano","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025121409283030000_12.2.e050510.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.1.47"},{"key":"2025121409283030000_12.2.e050510.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803955"},{"key":"2025121409283030000_12.2.e050510.7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-9-199805010-00003"},{"key":"2025121409283030000_12.2.e050510.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61543-7"},{"key":"2025121409283030000_12.2.e050510.9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.annonc.2020.02.012","article-title":"Aspirin and the risk of colorectal and other digestive tract cancers: an\u00a0updated meta-analysis through 2019","volume":"31","author":"Bosetti","year":"2020","journal-title":"Ann Oncol"},{"key":"2025121409283030000_12.2.e050510.10","unstructured":"U.S Preventive Services Task Force. aspirin use to prevent cardiovascular disease and colorectal cancer: preventive medication, 2016. Available: https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/RecommendationStatementFinal\/aspirin-to-prevent-cardiovascular-disease-and-cancer [Accessed 4 Oct 2020]."},{"key":"2025121409283030000_12.2.e050510.11","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0560"},{"key":"2025121409283030000_12.2.e050510.12","doi-asserted-by":"crossref","first-page":"e0160046","DOI":"10.1371\/journal.pone.0160046","article-title":"Bleeding risk with long-term low-dose aspirin: a systematic review of observational studies","volume":"11","author":"Garc\u00eda Rodr\u00edguez","year":"2016","journal-title":"PLoS One"},{"key":"2025121409283030000_12.2.e050510.13","doi-asserted-by":"crossref","DOI":"10.1038\/srep31755","article-title":"Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: the Beijing PLA Hospital atrial fibrillation project","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"key":"2025121409283030000_12.2.e050510.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.01.098"},{"key":"2025121409283030000_12.2.e050510.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.05.002"},{"key":"2025121409283030000_12.2.e050510.16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jnci\/djx267","article-title":"Aspirin and risk of gastric cancer after Helicobacter pylori eradication: a territory-wide study","volume":"110","author":"Cheung","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"2025121409283030000_12.2.e050510.17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314605"},{"key":"2025121409283030000_12.2.e050510.18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.03.049"},{"key":"2025121409283030000_12.2.e050510.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4664-5"},{"key":"2025121409283030000_12.2.e050510.20","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1702"},{"key":"2025121409283030000_12.2.e050510.21","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jamaoncol.2015.6396","article-title":"Population-Wide impact of long-term use of aspirin and the risk for cancer","volume":"2","author":"Cao","year":"2016","journal-title":"JAMA Oncol"},{"key":"2025121409283030000_12.2.e050510.22","doi-asserted-by":"crossref","first-page":"e0159179","DOI":"10.1371\/journal.pone.0159179","article-title":"The protective effect of low-dose aspirin against colorectal cancer is unlikely explained by selection bias: results from three different study designs in clinical practice","volume":"11","author":"Cea Soriano","year":"2016","journal-title":"PLoS One"},{"key":"2025121409283030000_12.2.e050510.23","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0039"},{"key":"2025121409283030000_12.2.e050510.24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.28634","article-title":"Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users","volume":"135","author":"Hollestein","year":"2014","journal-title":"Int J Cancer"},{"key":"2025121409283030000_12.2.e050510.25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/apt.12388","article-title":"The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study","volume":"38","author":"Huang","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121409283030000_12.2.e050510.26","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4143\/crt.2015.117","article-title":"Long-Term low-dose aspirin use reduces gastric cancer incidence: a nationwide cohort study","volume":"48","author":"Kim","year":"2016","journal-title":"Cancer Res Treat"},{"key":"2025121409283030000_12.2.e050510.27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/1751-2980.12047","article-title":"Role of aspirin in chemoprevention of esophageal adenocarcinoma: a meta-analysis","volume":"14","author":"Sivarasan","year":"2013","journal-title":"J Dig Dis"},{"key":"2025121409283030000_12.2.e050510.28","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/pds.4870","article-title":"Reduced risk of cancer among low-dose aspirin users: data from French health care databases","volume":"28","author":"Ajrouche","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025121409283030000_12.2.e050510.29","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-2-201307160-00002"},{"key":"2025121409283030000_12.2.e050510.30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166166"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-050510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:28:40Z","timestamp":1765733320000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-050510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,4]]},"published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1136\/bmjopen-2021-050510"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-050510","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}